ADMS

COM:ADAMASPHARMA

Supernus Pharmaceuticals

  • Stock

USD

Last Close

8.22

01/01 00:00

Volume Today

3.15M

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
net income
50.92M
-
10.22M
79.92%
-51.80M
606.72%
-60.06M
15.94%
-89.49M
49.01%
-131.00M
46.38%
-105.19M
19.70%
-57.40M
45.43%
depreciation and amortization
66K
-
155K
134.85%
435K
180.65%
808K
85.75%
1.19M
47.77%
1.46M
22.28%
1.21M
16.85%
851K
29.90%
deferred income tax
stock based compensation
640K
-
7.20M
1,025.47%
9.96M
38.22%
10.57M
6.18%
13.37M
26.45%
15.79M
18.10%
12.85M
18.59%
6.43M
49.96%
change in working capital
56.08M
-
29.19M
47.94%
-9.60M
132.89%
5.86M
161.07%
55.32M
843.45%
41.53M
24.93%
-80.72M
294.38%
-46.50M
42.39%
accounts receivables
761K
-
-395K
151.91%
-760K
92.41%
490K
164.47%
427K
12.86%
-5.14M
1,304.68%
-259K
94.97%
-2.27M
777.22%
inventory
-25.32M
-
-82.92M
227.49%
-109.43M
31.98%
-102.37M
6.45%
-1.65M
98.39%
-3.27M
98.85%
-970K
70.36%
-2.21M
127.32%
accounts payables
-1.16M
-
1.52M
231.46%
-788K
151.81%
502K
163.71%
333K
33.67%
2.76M
728.53%
398K
85.57%
-4.98M
1,351.01%
other working capital
81.79M
-
110.98M
35.69%
101.38M
8.65%
107.24M
5.78%
56.21M
47.59%
47.19M
16.05%
-79.89M
269.31%
-37.05M
53.63%
other non cash items
-80.90M
-
-20.58M
74.56%
3.80M
118.48%
-5.25M
238.13%
-47.22M
798.95%
-32.00M
32.24%
91.07M
384.59%
45.92M
49.58%
net cash provided by operating activities
26.80M
-
26.19M
2.26%
-47.21M
280.23%
-48.07M
1.82%
-66.83M
39.03%
-104.22M
55.96%
-80.78M
22.49%
-50.71M
37.23%
investments in property plant and equipment
-167K
-
-1.28M
669.46%
-1.40M
8.87%
-1.62M
16.08%
-1.26M
22.54%
-1.06M
15.42%
-18K
98.31%
acquisitions net
purchases of investments
-96.09M
-
-59.83M
37.74%
-103.53M
73.04%
-62.51M
39.62%
-200.35M
220.52%
-93.87M
53.15%
-68.94M
26.56%
sales maturities of investments
69.28M
-
78.44M
13.22%
89.33M
13.88%
132.08M
47.85%
182.75M
38.36%
123.88M
32.22%
other investing activites
net cash used for investing activites
-167K
-
-97.38M
58,211.38%
8.06M
108.27%
-26.71M
431.46%
25.57M
195.72%
-69.34M
371.22%
88.86M
228.16%
54.94M
38.17%
debt repayment
-4M
-
-2.65M
-
common stock issued
21K
-
42.63M
202,909.52%
9.66M
77.35%
61.82M
540.18%
134.27M
-
1.04M
-
common stock repurchased
-370K
-
dividends paid
other financing activites
4.76M
-
1.15M
75.77%
3.59M
211.01%
108.84M
2,935.22%
4.58M
95.79%
1.08M
76.32%
3.26M
200.74%
net cash used provided by financing activities
-3.98M
-
47.02M
1,281.70%
10.81M
77.01%
65.41M
505.07%
108.84M
66.41%
138.85M
27.57%
1.08M
99.22%
1.65M
52.44%
effect of forex changes on cash
net change in cash
22.66M
-
-24.17M
206.67%
-28.34M
17.28%
-9.37M
66.94%
67.58M
821.33%
-34.71M
151.36%
9.17M
126.42%
5.89M
35.81%
cash at beginning of period
62.96M
-
85.61M
35.98%
61.45M
28.23%
33.10M
46.13%
23.73M
28.30%
91.32M
284.73%
56.60M
38.01%
65.77M
16.20%
cash at end of period
85.61M
-
61.45M
28.23%
33.10M
46.13%
23.73M
28.30%
91.32M
284.73%
56.60M
38.01%
65.77M
16.20%
71.66M
8.95%
operating cash flow
26.80M
-
26.19M
2.26%
-47.21M
280.23%
-48.07M
1.82%
-66.83M
39.03%
-104.22M
55.96%
-80.78M
22.49%
-50.71M
37.23%
capital expenditure
-167K
-
-1.28M
669.46%
-1.40M
8.87%
-1.62M
16.08%
-1.26M
22.54%
-1.06M
15.42%
-18K
98.31%
free cash flow
26.63M
-
24.91M
6.48%
-48.61M
295.15%
-49.69M
2.23%
-68.08M
37.01%
-105.29M
54.64%
-80.80M
23.26%
-50.71M
37.24%

All numbers in USD (except ratios and percentages)